An MRI milestone was reached in mid-December when Toshiba America Medical Systems shipped its 300th Opart MRI scanner. The superconducting open system with a field strength of 0.35 tesla entered the market some three years ago. It was designed
An MRI milestone was reached in mid-December when Toshiba America Medical Systems shipped its 300th Opart MRI scanner. The superconducting open system with a field strength of 0.35 tesla entered the market some three years ago. It was designed specifically for the U.S. marketplace, where most have been sold. Ironically, the 300th unit was delivered to Toshiba Medical Systems Europe, which will install the product at a site in Italy.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.